Activity

Filter

Cancel
Date Panel Item Activity
5 actions
Genetic Epilepsy v1.412 SLC20A2 Zornitza Stark Marked gene: SLC20A2 as ready
Genetic Epilepsy v1.412 SLC20A2 Zornitza Stark Gene: slc20a2 has been classified as Amber List (Moderate Evidence).
Genetic Epilepsy v1.412 SLC20A2 Zornitza Stark Classified gene: SLC20A2 as Amber List (moderate evidence)
Genetic Epilepsy v1.412 SLC20A2 Zornitza Stark Gene: slc20a2 has been classified as Amber List (Moderate Evidence).
Genetic Epilepsy v1.411 SLC20A2 Zornitza Stark gene: SLC20A2 was added
gene: SLC20A2 was added to Genetic Epilepsy. Sources: Literature
Mode of inheritance for gene: SLC20A2 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SLC20A2 were set to 41458256; 35881308
Phenotypes for gene: SLC20A2 were set to Basal ganglia calcification, idiopathic, 1, MIM# 213600
Review for gene: SLC20A2 was set to AMBER
Added comment: PMID 41458256: Reports a single individual a homozygous nonsense SLC20A2 variant presenting with infantile primary familial brain calcification, cerebral arterial vasculopathy and ischaemic stroke. Individual exhibited seizures, hypotonia, poor feeding, and extensive ischaemic changes.

PMID 35881308: reports two siblings from a consanguineous Turkish family with a homozygous splice‑site loss‑of‑function variant NM_006749.5:c.1794+1G>A. The affected children presented with severe paediatric‑onset features resembling congenital CMV infection: growth retardation, bilateral cataracts, microcephaly, seizures, cerebral atrophy, corpus callosum hypoplasia and brain microcalcifications.

Gene is classically associated with a milder mono-allelic disorder, which typically does not involve seizures.
Sources: Literature